These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11822816)
1. Insulin in tissue engineering of cartilage: a potential model system for growth factor application. Kellner K; Schulz MB; Göpferich A; Blunk T J Drug Target; 2001; 9(6):439-48. PubMed ID: 11822816 [TBL] [Abstract][Full Text] [Related]
2. Biomaterial effects in articular cartilage tissue engineering using polyglycolic acid, a novel marine origin biomaterial, IGF-I, and TGF-beta 1. DiCarlo BB; Hu JC; Gross T; Vago R; Athanasiou KA Proc Inst Mech Eng H; 2009 Jan; 223(1):63-73. PubMed ID: 19239068 [TBL] [Abstract][Full Text] [Related]
4. IGF-I and mechanical environment interact to modulate engineered cartilage development. Gooch KJ; Blunk T; Courter DL; Sieminski AL; Bursac PM; Vunjak-Novakovic G; Freed LE Biochem Biophys Res Commun; 2001 Sep; 286(5):909-15. PubMed ID: 11527385 [TBL] [Abstract][Full Text] [Related]
5. Differential morphology and homogeneity of tissue-engineered cartilage in hydrodynamic cultivation with transient exposure to insulin-like growth factor-1 and transforming growth factor-β1. Yang YH; Barabino GA Tissue Eng Part A; 2013 Nov; 19(21-22):2349-60. PubMed ID: 23672482 [TBL] [Abstract][Full Text] [Related]
6. Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF-2 during 2D expansion and BMP-2 during 3D cultivation. Martin I; Suetterlin R; Baschong W; Heberer M; Vunjak-Novakovic G; Freed LE J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):121-8. PubMed ID: 11500960 [TBL] [Abstract][Full Text] [Related]
7. Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy. Munirah S; Samsudin OC; Aminuddin BS; Ruszymah BH Tissue Cell; 2010 Oct; 42(5):282-92. PubMed ID: 20810142 [TBL] [Abstract][Full Text] [Related]
8. Polymer scaffolds fabricated with pore-size gradients as a model for studying the zonal organization within tissue-engineered cartilage constructs. Woodfield TB; Van Blitterswijk CA; De Wijn J; Sims TJ; Hollander AP; Riesle J Tissue Eng; 2005; 11(9-10):1297-311. PubMed ID: 16259586 [TBL] [Abstract][Full Text] [Related]
9. Alginate encapsulation impacts the insulin-like growth factor-I system of monolayer-expanded equine articular chondrocytes and cell response to interleukin-1beta. Porter RM; Akers RM; Howard RD; Forsten-Williams K Tissue Eng; 2007 Jun; 13(6):1333-45. PubMed ID: 17518712 [TBL] [Abstract][Full Text] [Related]
10. Addition of hyaluronic acid to alginate embedded chondrocytes interferes with insulin-like growth factor-1 signaling in vitro and in vivo. Yoon DM; Curtiss S; Reddi AH; Fisher JP Tissue Eng Part A; 2009 Nov; 15(11):3449-59. PubMed ID: 19426107 [TBL] [Abstract][Full Text] [Related]
11. Effects of FGF-2 and IGF-1 on adult canine articular chondrocytes in type II collagen-glycosaminoglycan scaffolds in vitro. Veilleux N; Spector M Osteoarthritis Cartilage; 2005 Apr; 13(4):278-86. PubMed ID: 15780641 [TBL] [Abstract][Full Text] [Related]
12. Gene transfer of a human insulin-like growth factor I cDNA enhances tissue engineering of cartilage. Madry H; Padera R; Seidel J; Langer R; Freed LE; Trippel SB; Vunjak-Novakovic G Hum Gene Ther; 2002 Sep; 13(13):1621-30. PubMed ID: 12228017 [TBL] [Abstract][Full Text] [Related]
13. A cartilage tissue engineering approach combining starch-polycaprolactone fibre mesh scaffolds with bovine articular chondrocytes. Oliveira JT; Crawford A; Mundy JM; Moreira AR; Gomes ME; Hatton PV; Reis RL J Mater Sci Mater Med; 2007 Feb; 18(2):295-302. PubMed ID: 17323161 [TBL] [Abstract][Full Text] [Related]
14. Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Moretti M; Wendt D; Dickinson SC; Sims TJ; Hollander AP; Kelly DJ; Prendergast PJ; Heberer M; Martin I Tissue Eng; 2005; 11(9-10):1421-8. PubMed ID: 16259597 [TBL] [Abstract][Full Text] [Related]
16. Comparison of different chondrocytes for use in tissue engineering of cartilage model structures. Isogai N; Kusuhara H; Ikada Y; Ohtani H; Jacquet R; Hillyer J; Lowder E; Landis WJ Tissue Eng; 2006 Apr; 12(4):691-703. PubMed ID: 16674284 [TBL] [Abstract][Full Text] [Related]
17. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. Pei M; Seidel J; Vunjak-Novakovic G; Freed LE Biochem Biophys Res Commun; 2002 May; 294(1):149-54. PubMed ID: 12054755 [TBL] [Abstract][Full Text] [Related]
18. Effects of exogenous IGF-1 delivery on the early expression of IGF-1 signaling molecules by alginate embedded chondrocytes. Yoon DM; Fisher JP Tissue Eng Part A; 2008 Jul; 14(7):1263-73. PubMed ID: 18491951 [TBL] [Abstract][Full Text] [Related]
19. Poly(lactide-co-glycolide) microspheres as a moldable scaffold for cartilage tissue engineering. Mercier NR; Costantino HR; Tracy MA; Bonassar LJ Biomaterials; 2005 May; 26(14):1945-52. PubMed ID: 15576168 [TBL] [Abstract][Full Text] [Related]
20. The effect of growth factor treatment on meniscal chondrocyte proliferation and differentiation on polyglycolic acid scaffolds. Stewart K; Pabbruwe M; Dickinson S; Sims T; Hollander AP; Chaudhuri JB Tissue Eng; 2007 Feb; 13(2):271-80. PubMed ID: 17504061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]